breast cancer

Celcuity

Pharma

Celcuity set to be Big Pharma 'strategic target' after approval

The biotech's Revtorpyk, also in development for prostate cancer and other solid tumors, has the potential to generate multibillion-dollar sales.

Darren Incorvaia Jul 14, 2026 4:56pm

reputation rating ranking

Roche tops cancer reputation rankings as AstraZeneca climbs back

Jul 2, 2026 6:00am

Gilead

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm

Green traffic light

FDA approves breast cancer expansion for Pfizer's Ibrance

Jun 24, 2026 2:48pm

Roche

Fierce Biotech

Roche oral SERD's 1st-line miss spurs new adjuvant trial

Jun 2, 2026 12:45pm

Fierce Biotech

FDA delays ruling on AstraZeneca drug after negative adcomm vote

May 27, 2026 4:43am